Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Response to Lai.

Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS.

Am J Gastroenterol. 2019 Jul;114(7):1177-1178. doi: 10.14309/ajg.0000000000000312. No abstract available.

PMID:
31205133
2.

Response to Sierra and Gomez.

Schoenfeld P, Shah ED.

Am J Gastroenterol. 2019 Jan;114(1):169-170. doi: 10.14309/ajg.0000000000000066. No abstract available.

PMID:
30633033
3.

Evidence-Based Guidelines for Screening Individuals With a Family History of Colorectal Cancer- More Questions Than Answers.

Schoenfeld P.

Gastroenterology. 2018 Nov;155(5):1298-1300. doi: 10.1053/j.gastro.2018.10.014. Epub 2018 Oct 8. No abstract available.

PMID:
30308192
4.

Adherence to CRC Screening and Surveillance Guidelines when Using Split-Dose Bowel Preparation.

Menees SB, Kim HM, Elta GH, Korsnes S, Schoenfeld P.

Gastroenterol Res Pract. 2018 Jul 2;2018:8237824. doi: 10.1155/2018/8237824. eCollection 2018.

5.

Response to Griffin.

Schoenfeld P.

Am J Gastroenterol. 2018 Sep;113(9):1395-1396. doi: 10.1038/s41395-018-0197-2. Epub 2018 Jul 25. No abstract available.

PMID:
30042548
6.
7.

Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.

Shah ED, Kim HM, Schoenfeld P.

Am J Gastroenterol. 2018 Mar;113(3):329-338. doi: 10.1038/ajg.2017.495. Epub 2018 Jan 30.

PMID:
29380823
8.

Why don't endoscopists follow guideline recommendations and how can we improve adherence?

Schoenfeld P.

Endoscopy. 2018 Feb;50(2):93-95. doi: 10.1055/s-0043-124871. Epub 2018 Jan 29. No abstract available.

PMID:
29378370
9.

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

Schoenfeld P, Lacy BE, Chey WD, Lembo AJ, Kurtz CB, Reasner DS, Bochenek W, Tripp K, Currie MG, Fox SM, Blakesley RE, OʼDea CR, Omniewski ND, Hall ML.

Am J Gastroenterol. 2018 Jan;113(1):105-114. doi: 10.1038/ajg.2017.230. Epub 2017 Aug 22.

10.

Factors Associated with Surveillance Adenoma and Sessile Serrated Polyp Detection Rates.

Maratt JK, Dickens J, Schoenfeld PS, Elta GH, Jackson K, Rizk D, Erickson C, Menees SB.

Dig Dis Sci. 2017 Dec;62(12):3579-3585. doi: 10.1007/s10620-017-4792-7. Epub 2017 Oct 17.

11.

Response to Croteau and Barkin.

Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS.

Am J Gastroenterol. 2017 Oct;112(10):1617. doi: 10.1038/ajg.2017.256. No abstract available.

PMID:
28978962
12.

Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder.

Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS.

Am J Gastroenterol. 2017 Oct;112(10):1619-1620. doi: 10.1038/ajg.2017.257. No abstract available.

PMID:
28978951
13.

Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.

Pimentel M, Cash BD, Lembo A, Wolf RA, Israel RJ, Schoenfeld P.

Dig Dis Sci. 2017 Oct;62(10):2945. doi: 10.1007/s10620-017-4729-1. No abstract available.

14.

Who is Responsible for What Happens Before, During, and After Colonoscopy? Results of a National Survey of Primary Care Physicians.

Read AJ, Weissman A, Schoenfeld PS, Saini S, Menees SB, Saini SD.

J Clin Gastroenterol. 2018 Jul;52(6):e44-e47. doi: 10.1097/MCG.0000000000000881.

PMID:
28737648
15.

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.

Pimentel M, Cash BD, Lembo A, Wolf RA, Israel RJ, Schoenfeld P.

Dig Dis Sci. 2017 Sep;62(9):2455-2463. doi: 10.1007/s10620-017-4598-7. Epub 2017 Jun 6. Erratum in: Dig Dis Sci. 2017 Sep 7;:.

16.

Advances in IBS 2016: A Review of Current and Emerging Data.

Schoenfeld PS.

Gastroenterol Hepatol (N Y). 2016 Aug;12(8 Suppl 3):1-11.

17.

Ten-year intervals between screening colonoscopies: it's not too long.

Schoenfeld P.

Gastrointest Endosc. 2017 Jan;85(1):225-227. doi: 10.1016/j.gie.2016.09.021. No abstract available.

PMID:
27986113
18.

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.

Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS.

Am J Gastroenterol. 2017 Feb;112(2):365-374. doi: 10.1038/ajg.2016.542. Epub 2016 Dec 6.

19.

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, Paterson C, Bortey E, Forbes WP.

Gastroenterology. 2016 Dec;151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13.

20.

How Efficacious Are Patient Education Interventions to Improve Bowel Preparation for Colonoscopy? A Systematic Review.

Kurlander JE, Sondhi AR, Waljee AK, Menees SB, Connell CM, Schoenfeld PS, Saini SD.

PLoS One. 2016 Oct 14;11(10):e0164442. doi: 10.1371/journal.pone.0164442. eCollection 2016. Review.

21.

Predictors of suboptimal bowel preparation in asymptomatic patients undergoing average-risk screening colonoscopy.

Govani SM, Elliott EE, Menees SB, Judd SL, Saini SD, Anastassiades CP, Urganus AL, Boyce SJ, Schoenfeld PS.

World J Gastrointest Endosc. 2016 Sep 16;8(17):616-22. doi: 10.4253/wjge.v8.i17.616.

22.

The Effect of Endoscopist Recommendations on PCPs Choosing Wisely about Colonoscopy.

Read AJ, Weissman A, Schoenfeld PS, Saini S, Menees SB, Saini SD.

Am J Gastroenterol. 2016 May;111(5):749-51. doi: 10.1038/ajg.2016.77. No abstract available.

PMID:
27151128
23.

Corrigendum: Status of Competency-Based Medical Education in Endoscopy Training: A Nationwide Survey of US ACGME-Accredited Gastroenterology Training Programs.

Patel SG, Keswani R, Elta G, Saini S, Menard-Katcher P, Del Valle J, Hosford L, Myers A, Ahnen D, Schoenfeld P, Wani S.

Am J Gastroenterol. 2016 Apr;111(4):585. doi: 10.1038/ajg.2016.87. No abstract available.

PMID:
27125721
24.

Developing and Testing an Electronic Measure of Screening Colonoscopy Overuse in a Large Integrated Healthcare System.

Saini SD, Powell AA, Dominitz JA, Fisher DA, Francis J, Kinsinger L, Pittman KS, Schoenfeld P, Moser SE, Vijan S, Kerr EA.

J Gen Intern Med. 2016 Apr;31 Suppl 1:53-60. doi: 10.1007/s11606-015-3569-y.

25.

No Polyp Left Behind: Defining Bowel Preparation Adequacy to Avoid Missed Polyps.

Schoenfeld P, Dominitz JA.

Gastroenterology. 2016 Feb;150(2):303-6. doi: 10.1053/j.gastro.2015.12.024. Epub 2015 Dec 20. No abstract available.

PMID:
26713765
26.

Reply to Sharma.

Patel SG, Keswani RN, Del Valle J, Schoenfeld P, Wani S.

Am J Gastroenterol. 2015 Nov;110(11):1628-9. doi: 10.1038/ajg.2015.335. No abstract available.

PMID:
26618429
27.

Real-Time Characterization of Diminutive Colorectal Polyp Histology Using Narrow-Band Imaging: Implications for the Resect and Discard Strategy.

Patel SG, Schoenfeld P, Kim HM, Ward EK, Bansal A, Kim Y, Hosford L, Myers A, Foster S, Craft J, Shopinski S, Wilson RH, Ahnen DJ, Rastogi A, Wani S.

Gastroenterology. 2016 Feb;150(2):406-18. doi: 10.1053/j.gastro.2015.10.042. Epub 2015 Oct 30.

28.

Response.

Rex DK, Schoenfeld PS.

Gastrointest Endosc. 2015 Aug;82(2):421-2. doi: 10.1016/j.gie.2015.02.032. No abstract available.

PMID:
26183497
29.

Open letter to the Secretaries of the U.S. Departments of Agriculture and Health and Human Services on the creation of the 2015 Dietary Guidelines for Americans.

Hite AH, Schoenfeld P.

Nutrition. 2015 May;31(5):776-9. doi: 10.1016/j.nut.2014.12.019. Epub 2015 Jan 3. No abstract available.

PMID:
25837226
30.

Status of Competency-Based Medical Education in Endoscopy Training: A Nationwide Survey of US ACGME-Accredited Gastroenterology Training Programs.

Patel SG, Keswani R, Elta G, Saini S, Menard-Katcher P, Del Valle J, Hosford L, Myers A, Ahnen D, Schoenfeld P, Wani S.

Am J Gastroenterol. 2015 Jul;110(7):956-62. doi: 10.1038/ajg.2015.24. Epub 2015 Mar 24. Erratum in: Am J Gastroenterol. 2016 Apr;111(4):585.

PMID:
25803401
31.

Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis.

Elmunzer BJ, Singal AG, Sussman JB, Deshpande AR, Sussman DA, Conte ML, Dwamena BA, Rogers MA, Schoenfeld PS, Inadomi JM, Saini SD, Waljee AK.

Gastrointest Endosc. 2015 Mar;81(3):700-709.e3. doi: 10.1016/j.gie.2014.10.033.

32.

Quality indicators for colonoscopy.

Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS.

Gastrointest Endosc. 2015 Jan;81(1):31-53. doi: 10.1016/j.gie.2014.07.058. Epub 2014 Dec 2. Review. No abstract available.

PMID:
25480100
33.

Quality indicators for colonoscopy.

Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS.

Am J Gastroenterol. 2015 Jan;110(1):72-90. doi: 10.1038/ajg.2014.385. Epub 2014 Dec 2. No abstract available.

PMID:
25448873
34.

The increasing importance of quality measures for trainees.

Saini SD, Waljee AK, Schoenfeld P, Kerr EA, Vijan S.

Gastroenterology. 2014 Oct;147(4):725-9. doi: 10.1053/j.gastro.2014.08.027. Epub 2014 Aug 23. No abstract available.

35.

Response to Feuerstein et al.

Schoenfeld P.

Am J Gastroenterol. 2014 Aug;109(8):1289-90. doi: 10.1038/ajg.2014.173. No abstract available.

PMID:
25091248
36.

Editorial: safety and tolerability of rifaximin for IBS - more information is required; authors' reply.

Schoenfeld P, Pimentel M.

Aliment Pharmacol Ther. 2014 Jul;40(2):209. doi: 10.1111/apt.12837. No abstract available.

37.

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials.

Schoenfeld P, Pimentel M, Chang L, Lembo A, Chey WD, Yu J, Paterson C, Bortey E, Forbes WP.

Aliment Pharmacol Ther. 2014 May;39(10):1161-8. doi: 10.1111/apt.12735. Epub 2014 Apr 3.

38.

Patient compliance and suboptimal bowel preparation with split-dose bowel regimen in average-risk screening colonoscopy.

Menees SB, Kim HM, Wren P, Zikmund-Fisher BJ, Elta GH, Foster S, Korsnes S, Graustein B, Schoenfeld P.

Gastrointest Endosc. 2014 May;79(5):811-820.e3. doi: 10.1016/j.gie.2014.01.024. Epub 2014 Mar 13.

39.

Adherence to recommended intervals for surveillance colonoscopy in average-risk patients with 1 to 2 small (<1 cm) polyps on screening colonoscopy.

Menees SB, Elliott E, Govani S, Anastassiades C, Schoenfeld P.

Gastrointest Endosc. 2014 Apr;79(4):551-7. doi: 10.1016/j.gie.2014.01.029.

40.

Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study.

Saini SD, Vijan S, Schoenfeld P, Powell AA, Moser S, Kerr EA.

BMJ. 2014 Feb 26;348:g1247. doi: 10.1136/bmj.g1247.

41.

The impact of bowel cleansing on follow-up recommendations in average-risk patients with a normal colonoscopy.

Menees SB, Elliott E, Govani S, Anastassiades C, Judd S, Urganus A, Boyce S, Schoenfeld P.

Am J Gastroenterol. 2014 Feb;109(2):148-54. doi: 10.1038/ajg.2013.243.

42.

Quality indicators for colorectal cancer screening for colonoscopy.

Schoenfeld PS, Cohen J.

Tech Gastrointest Endosc. 2013 Apr;15(2):59-68.

43.

Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.

Rubenstein JH, Morgenstern H, McConell D, Scheiman JM, Schoenfeld P, Appelman H, McMahon LF Jr, Kao JY, Metko V, Zhang M, Inadomi JM.

Gastroenterology. 2013 Dec;145(6):1237-44.e1-5. doi: 10.1053/j.gastro.2013.08.052. Epub 2013 Aug 30.

44.

Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms.

Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M, Metko V, Kao JY.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):239-45. doi: 10.1016/j.cgh.2013.08.029. Epub 2013 Aug 27.

45.

Intraprocedural quality in endoscopic retrograde cholangiopancreatography: a meta-analysis.

DeBenedet AT, Elmunzer BJ, McCarthy ST, Elta GH, Schoenfeld PS.

Am J Gastroenterol. 2013 Nov;108(11):1696-704; quiz 1705. doi: 10.1038/ajg.2013.217. Epub 2013 Jul 23.

46.

Don't forget about constipation with opioid treatment of chronic non-cancer pain.

Ford AC, Brenner DM, Schoenfeld PS.

BMJ. 2013 Jul 16;347:f4492. doi: 10.1136/bmj.f4492. No abstract available.

PMID:
23861421
47.

Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.

Ford AC, Brenner DM, Schoenfeld PS.

Am J Gastroenterol. 2013 Oct;108(10):1566-74; quiz 1575. doi: 10.1038/ajg.2013.169. Epub 2013 Jun 11. Review.

PMID:
23752879
48.

The impact of fair colonoscopy preparation on colonoscopy use and adenoma miss rates in patients undergoing outpatient colonoscopy.

Menees SB, Kim HM, Elliott EE, Mickevicius JL, Graustein BB, Schoenfeld PS.

Gastrointest Endosc. 2013 Sep;78(3):510-6. doi: 10.1016/j.gie.2013.03.1334. Epub 2013 Apr 30.

49.

Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus.

Rubenstein JH, Morgenstern H, Chey WD, Murray J, Scheiman JM, Schoenfeld P, Appelman HD, McMahon L, Metko V, Kellenberg J, Kalish T, Baker J, Inadomi JM.

Gut. 2014 Feb;63(2):230-5. doi: 10.1136/gutjnl-2012-304103. Epub 2013 Mar 5.

50.

Can the adenoma detection rate reliably identify low-performing endoscopists? Results of a modeling study.

Saini SD, Schoenfeld P, Vijan S.

Dig Dis Sci. 2013 Jul;58(7):1856-62. doi: 10.1007/s10620-013-2592-2. Epub 2013 Mar 2.

PMID:
23456494

Supplemental Content

Loading ...
Support Center